Serotonin promotes aggressive features in breast cancer cells by modulating proliferation and migration, hormone receptors and HER2 expression
Authors:
- José Xavier Do Nascimento JuniorJJJosé Xavier Do Nascimento Junior
- Maria Eduarda Sant'ANa Faria Do Espírito SantoMSMaria Eduarda Sant'ANa Faria Do Espírito Santo
- João Gabriel Bernardo LeandroJLJoão Gabriel Bernardo Leandro
- Davi MundimDMDavi Mundim
- Jessica Ristow BrancoJBJessica Ristow Branco
- Sérgio T. FerreiraSFSérgio T. Ferreira
- Patricia ZancanPZPatricia Zancan
- 31 October 2025
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 612, 112692
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Sacatar Foundation
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Universidade Federal do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 84 references indexed in Scilit:
- In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancerClinical and Translational Medicine, 2022
- The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based studyInternational Journal of Clinical Oncology, 2022
- Clotrimazole presents anticancer properties against a mouse melanoma model acting as a PI3K inhibitor and inducing repolarization of tumor-associated macrophagesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patientsJournal of Cancer Research and Clinical Oncology, 2021
- LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cellsMolecular Oncology, 2017
- Signal-dependent Elk-1 target genes involved in transcript processing and cell migrationBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013
- Overexpression of p53 protein in human tumorsMedical Molecular Morphology, 2012
- Angiopoietin-2: Development of inhibitors for cancer therapyCurrent Oncology Reports, 2009
- High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosisCancer, 2003
- Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancerJournal of Cellular Physiology, 2001